NDC 51662-1326-2 - 2% LIDOCAINE HCI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1326
- Requested NDC
- 51662-1326-2
- Package NDCs from labels
- 51662-1326-1, 51662-1326-2, 51662-1326-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 2% LIDOCAINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1326-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
| 51662-1326-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1326-1 | 2% LIDOCAINE HCI | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 7 | |
| 51662-1326-2 | 2% LIDOCAINE HCI | 1 mL in 1 POUCH | INJECTION, SOLUTION | 1 | 7 | |
| 51662-1326-3 | 2% LIDOCAINE HCI | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1326 | 2% LIDOCAINE HCI INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240130_78d8fb0a-bfae-6599-e053-2991aa0a2e03.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Theraworx Pain Relief Roll- On- Lidocaine | LIDOCAINE HYDROCHLORIDE | AVADIM HOLDINGS, INC. | b4ce3876-f9e3-43ca-810b-75fbe6f887b6 | 2026-10-08 | Warnings | V13007Z41A |
| PAIN RELIEF Gel-Roll On | LIDOCAINE HYDROCHLORIDE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 5d51de1a-2166-4417-e063-6394a90adce5 | 2026-10-08 | Warnings | V13007Z41A |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Safco Dental Supply Co | 6721c3ab-c37f-4504-aebc-0103c56ed567 | 2026-10-08 | Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 55a8372e-70d6-4b70-ac95-5226d0f5812a | 2026-10-07 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 5b74b6f4-f26f-4243-8060-cd1777907984 | 2026-10-07 | Warnings, Adverse reactions | 1737566 V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Sandoz Inc. | dc476ebd-fd57-41c3-a649-7185a784a39f | 2026-10-06 | Warnings, Adverse reactions | 1737757 1737562 1737566 1737568 V13007Z41A |
| Nervive Pain Relieving | LIDOCAINE HCL AND MENTHOL | The Procter & Gamble Manufacturing Company | 32f8d0f3-d18d-1a45-e063-6294a90a6ad3 | 2026-10-05 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 5692e28d-559c-4b6a-8421-fa85d7155818 | 2026-10-05 | Warnings, Adverse reactions | V13007Z41A |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| 5Kind Maximum Strength Pain Relieving Lidocaine HCl Hemp | LIDOCAINE HYDROCHLORIDE | 5Kind Trading LTD | c2df4c90-2b9e-460a-8f54-5d824b484163 | 2026-10-02 | Warnings | V13007Z41A |
| Meijer Maximum strength pain relieving cleansing | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | MEIJER DISTRIBUTION, INC. | d7d63abe-d1ff-4a8d-bfa7-35c63dfbf857 | 2026-10-01 | Warnings | V13007Z41A |
| First Aid Only First Aid/Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE CREAM | Acme United Corporation | 5cc8418f-a285-4240-e063-6294a90a7bf3 | 2026-10-01 | Warnings | V13007Z41A |
| BVibe | LIDOCAINE HCL DELAY SPRAY | COTR Inc | 39bfb77f-090a-9ef1-e063-6294a90a5644 | 2026-09-29 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.